Its gone through the usual channels from pharmacy to Medicare Advantage to (at this point) nowhere
In this context, GLP-1 therapies are best understood as one component within a broader strategy
Protective effects of melatonin against cyclophosphamide-induced oxidative lung toxicity in mice
There is some interest in using IGF1-LR3 to reduce the side effects of glucocorticoids and thus allow for more effective therapy [6]
Nekothione is registered by the Philippine Food and Drug Administration as a food supplement with no approved therapeutic claims
Patients with T2DM initiating GLP-1 RAs or metformin as first-line monotherapy were included (87,229 matched patients per cohort).The researchers found that compared with metformin, GLP-1 RA use was associated with a significantly lower risk for overall dementia, Alzheimer disease, and nonvascular dementias (adjusted hazard ratios, 0.90, 0.88, and 0.75, respectively)